MASS OPPORTUNITIES


Oct 31, 01

10:35 ET Ardais Announces Commercial Launch of its Clinical Genomics Resource

 
10:01 ET Massachusetts Biotechnology Investors' Conference Shatters Attendance Record

 
09:23 ET Waratah Pharmaceuticals to Present at Mass Opportunities Investor Conference

 
07:59 ET Aphios Kicks-off Mezzanine Round Capital Campaign

 
07:05 ET BioTrove Announces Participation at The Massachusetts Biotechnology Council Annual Investors Conference.

 
Oct 30, 01

11:50 ET Novirio Pharmaceuticals to Present at The Mass Opportunities Biotechnology Investor Conference

 
09:18 ET Coley Pharmaceutical Group Begins Phase I/II Trial of CpG 7909 in Combination with Herceptin (R) to Treat Breast Cancer

 
07:59 ET Therion Completes $36.5 Million Private Financing to Advance Clinical Development of Therapeutic Cancer Vaccines

 
Oct 29, 01

15:43 ET Cetek Corporation Launches Natural Products Drug Discovery Initiative at Mass Opportunities Investor Conference

 
14:53 ET Genome Therapeutics Announces Audio Access to Mass Opportunities Investor Conference Presentation

 
12:25 ET Paratek Pharmaceuticals to Present at Massachusetts Biotech Council Conference

 
09:13 ET Genzyme Molecular Oncology to Present at Two Major Investor Conferences

 
Oct 26, 01

18:52 ET Silicon Valley Bank to Co-Sponsor Mass Opportunities: A Biotechnology Investment Conference October 30-31

 
Oct 25, 01

17:23 ET Massachusetts Biotechnology Council's Conference Empowers Investors to Get Back to Business

 
16:34 ET Altus Turning Proteins into Products(TM)

 
13:47 ET VITEX to Present at Massachusetts Opportunities Investment Conference on October 30

 
Oct 24, 01

12:51 ET AmberGen, Inc. Promises to Speed Up Drug Discovery

 
12:01 ET Millennium Pharmaceuticals Announces Webcast of Presentation at The Mass Opportunities Investor Conference

    
Sep 27, 01

15:16 ET Prominent Merck and Compaq Executives to Keynote Region's Largest Biotechnology Investor Conference, MASS Opportunities

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.